Skip to main content

Table 5 Comparison of baseline and post-treatment SUV in PD, SD, and PR groups

From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma

  Progressive disease (N = 3) Stable disease (N = 9) Partial response (N = 7)
Pre-treatment Post-treatment P-value Pre-treatment Post-treatment P-value Pre-treatment Post-treatment P-value
SUV
 Mean 5.97 12.37 0.14 17.23 13.41 0.09 14.04 5.3 0.0006
 SD 3.85 8.54   11.25 8.82   3.15 2.17  
  1. N number, SD standard deviation